Soluble antigen arrays improve the efficacy and safety of peptide-based tolerogenic immunotherapy
R. Firdessa Fite, S. N. Johnson, M. A. Leon, J. O. Sestak, C. Berkland, R. J. Creusot
This study shows that soluble antigen arrays (SAgAs) enhance the efficacy and safety of peptide-based immunotherapy compared to free peptides in treating autoimmune diabetes.
bioRxiv · May 5, 2023 · PreprintImmunology